Illumina (ILMN) : Simplex Trading added new position in Illumina during the most recent quarter end. The investment management firm now holds 4,173 shares of Illumina which is valued at $769,877 , the company said in a statement filed on Oct 7, 2016 with the SEC.Illumina makes up approximately 0.10% of Simplex Trading’s portfolio.
Other Hedge Funds, Including , Exxonmobil Investment Management Inc Tx reduced its stake in ILMN by selling 671 shares or 1.76% in the most recent quarter. The Hedge Fund company now holds 37,432 shares of ILMN which is valued at $6,905,830. Illumina makes up approx 0.14% of Exxonmobil Investment Management Inc Tx’s portfolio.Private Asset Management Inc boosted its stake in ILMN in the latest quarter, The investment management firm added 1,170 additional shares and now holds a total of 7,547 shares of Illumina which is valued at $1,405,025. Illumina makes up approx 0.24% of Private Asset Management Inc’s portfolio.Washington Trust Bank reduced its stake in ILMN by selling 4 shares or 17.39% in the most recent quarter. The Hedge Fund company now holds 19 shares of ILMN which is valued at $3,537.Eqis Capital Management reduced its stake in ILMN by selling 259 shares or 2.57% in the most recent quarter. The Hedge Fund company now holds 9,802 shares of ILMN which is valued at $1,824,838. Illumina makes up approx 0.11% of Eqis Capital Management’s portfolio.Norman Fields Gottscho Capital Management reduced its stake in ILMN by selling 389 shares or 4.84% in the most recent quarter. The Hedge Fund company now holds 7,644 shares of ILMN which is valued at $1,423,083. Illumina makes up approx 0.95% of Norman Fields Gottscho Capital Management’s portfolio.
Illumina closed down -0.44 points or -0.24% at $184.49 with 7,73,003 shares getting traded on Friday. Post opening the session at $185.82, the shares hit an intraday low of $183.6 and an intraday high of $185.99 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, Illumina reported $0.71 EPS for the quarter, missing the analyst consensus estimate by $ -0.03 based on the information available during the earnings call on May 3, 2016. Analyst had a consensus of $0.74. The company had revenue of $571.80 million for the quarter, compared to analysts expectations of $580.44 million. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 EPS.
Many Wall Street Analysts have commented on Illumina. Illumina was Downgraded by CL King to ” Neutral” on Aug 22, 2016. Company shares were Reiterated by Mizuho on Jul 27, 2016 to “Neutral”, Firm has raised the Price Target to $ 148 from a previous price target of $138 .
Illumina Inc. is engaged in production development of sequencing-and array-based solutions for genetic analysis. The Company offers integrated systems consumables and analysis tools for genetic analysis. It also manufactures sequencing and array platforms reagent kits and scanning equipment. Its customers include genomic research centers academic institutions government laboratories hospitals and reference laboratories pharmaceutical biotechnology agrigenomics commercial molecular diagnostic and consumer genomics companies. Its sequencing instruments perform a range of nucleic-acid analyses across a range of sample sizes. Its products and services are used for basic analysis and research including de novo sequencing genetic variation analysis epigenetics and targeted screening among others. It also provides products and services for other life sciences applied markets such as agrigenomics. It also offers Clarity Run Manager Clarity LIMS Silver and Clarity LIMS Gold.